Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,114,808
+$118,467 QoQ
Shares Held
8,327
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#2,302
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOUNDERS GROVE WEALTH PARTNERS, LLC holds $22,439,048 across 6 Drug Manufacturers - General names. JNJ ranks #2 (9.4% of the industry book) .
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,114,808 | 8,327 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,996,341 | 8,167 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,704,026 | 8,234 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $1,349,857 | 7,280 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,007,233 | 6,594 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,141,974 | 6,886 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $971,557 | 6,718 | Shares | Sole | 2025-01-14 | |
| No filing history on record for this holder in this stock. | ||||||